Cargando…

Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective

Numerous bacteria utilize molecular communication systems referred to as quorum sensing (QS) to synchronize the expression of certain genes regulating, among other aspects, the expression of virulence factors and the synthesis of biofilm. To achieve this process, bacteria use signaling molecules, kn...

Descripción completa

Detalles Bibliográficos
Autores principales: Rémy, Benjamin, Mion, Sonia, Plener, Laure, Elias, Mikael, Chabrière, Eric, Daudé, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845960/
https://www.ncbi.nlm.nih.gov/pubmed/29563876
http://dx.doi.org/10.3389/fphar.2018.00203
_version_ 1783305513389260800
author Rémy, Benjamin
Mion, Sonia
Plener, Laure
Elias, Mikael
Chabrière, Eric
Daudé, David
author_facet Rémy, Benjamin
Mion, Sonia
Plener, Laure
Elias, Mikael
Chabrière, Eric
Daudé, David
author_sort Rémy, Benjamin
collection PubMed
description Numerous bacteria utilize molecular communication systems referred to as quorum sensing (QS) to synchronize the expression of certain genes regulating, among other aspects, the expression of virulence factors and the synthesis of biofilm. To achieve this process, bacteria use signaling molecules, known as autoinducers (AIs), as chemical messengers to share information. Naturally occurring strategies that interfere with bacterial signaling have been extensively studied in recent years, examining their potential to control bacteria. To interfere with QS, bacteria use quorum sensing inhibitors (QSIs) to block the action of AIs and quorum quenching (QQ) enzymes to degrade signaling molecules. Recent studies have shown that these strategies are promising routes to decrease bacterial pathogenicity and decrease biofilms, potentially enhancing bacterial susceptibility to antimicrobial agents including antibiotics and bacteriophages. The efficacy of QSIs and QQ enzymes has been demonstrated in various animal models and are now considered in the development of new medical devices against bacterial infections, including dressings, and catheters for enlarging the therapeutic arsenal against bacteria.
format Online
Article
Text
id pubmed-5845960
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58459602018-03-21 Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective Rémy, Benjamin Mion, Sonia Plener, Laure Elias, Mikael Chabrière, Eric Daudé, David Front Pharmacol Pharmacology Numerous bacteria utilize molecular communication systems referred to as quorum sensing (QS) to synchronize the expression of certain genes regulating, among other aspects, the expression of virulence factors and the synthesis of biofilm. To achieve this process, bacteria use signaling molecules, known as autoinducers (AIs), as chemical messengers to share information. Naturally occurring strategies that interfere with bacterial signaling have been extensively studied in recent years, examining their potential to control bacteria. To interfere with QS, bacteria use quorum sensing inhibitors (QSIs) to block the action of AIs and quorum quenching (QQ) enzymes to degrade signaling molecules. Recent studies have shown that these strategies are promising routes to decrease bacterial pathogenicity and decrease biofilms, potentially enhancing bacterial susceptibility to antimicrobial agents including antibiotics and bacteriophages. The efficacy of QSIs and QQ enzymes has been demonstrated in various animal models and are now considered in the development of new medical devices against bacterial infections, including dressings, and catheters for enlarging the therapeutic arsenal against bacteria. Frontiers Media S.A. 2018-03-07 /pmc/articles/PMC5845960/ /pubmed/29563876 http://dx.doi.org/10.3389/fphar.2018.00203 Text en Copyright © 2018 Rémy, Mion, Plener, Elias, Chabrière and Daudé. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Rémy, Benjamin
Mion, Sonia
Plener, Laure
Elias, Mikael
Chabrière, Eric
Daudé, David
Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective
title Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective
title_full Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective
title_fullStr Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective
title_full_unstemmed Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective
title_short Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective
title_sort interference in bacterial quorum sensing: a biopharmaceutical perspective
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845960/
https://www.ncbi.nlm.nih.gov/pubmed/29563876
http://dx.doi.org/10.3389/fphar.2018.00203
work_keys_str_mv AT remybenjamin interferenceinbacterialquorumsensingabiopharmaceuticalperspective
AT mionsonia interferenceinbacterialquorumsensingabiopharmaceuticalperspective
AT plenerlaure interferenceinbacterialquorumsensingabiopharmaceuticalperspective
AT eliasmikael interferenceinbacterialquorumsensingabiopharmaceuticalperspective
AT chabriereeric interferenceinbacterialquorumsensingabiopharmaceuticalperspective
AT daudedavid interferenceinbacterialquorumsensingabiopharmaceuticalperspective